Stenocare A/S

Stenocare A/S FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Stenocare A/S (STENO.CO) as of Oct 17, 2026 is 301.70 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 20.83 % — a change of 1,348.09% (higher).

FCF Conversion

301.70 %

YoY

1,348.09%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Stenocare A/S is 2025 301.70 % . FCF Conversion Rate (FCF/EBITDA) of Stenocare A/S was 2024 20.83 % . It decreases by 1,348.09% higher compared to the previous year.

The Stenocare A/S FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
170.79 DKK
Jan 1, 2019
-642.59 DKK
Jan 1, 2020
265.08 DKK
Jan 1, 2021
130.48 DKK
Jan 1, 2022
97.95 DKK
Jan 1, 2023
58.15 DKK
Jan 1, 2024
20.83 DKK
Jan 1, 2025
301.70 DKK
The Stenocare A/S FCF Conversion history
YEARFCF ConversionYoY
301.70 %+1,348.09%
20.83 %-64.17%
58.15 %-40.63%
97.95 %-24.93%
130.48 %-50.78%
265.08 %-141.25%
-642.59 %-476.25%
170.79 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Stenocare A/S Stock analysis

What does Stenocare A/S do? Stenocare A/S is a Danish company operating in the Health Care sector, specifically within Pharmaceuticals. It engages in the cultivation, manufacture, and distribution of medical cannabis products. The company has two divisions: importing and wholesaling finished medical cannabis products for Danish patients, and operating its own cultivation and production facility in Denmark to produce finished cannabis products for Danish and European patients. Products are distributed through pharmacies and hospitals. The company is listed on the Copenhagen Stock Exchange with ticker STENO.CO and ISIN DK0061078425. Its headquarters are located in Randers, Denmark. IPO date was October 26, 2018. Stenocare A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Stenocare A/S stock

FCF Conversion Rate (FCF/EBITDA) of Stenocare A/S is 301.70 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Stenocare A/S changed from 20.83 % to 301.70 %, representing a 1,348.09% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Stenocare A/S since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Stenocare A/S with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Stenocare A/S

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Stenocare A/S